Trial intelligence / Profile preview

St. John's Wort in OCD

NCT00035438Phase 2Completed

Sponsor
National Center for Complementary and Integrative Health
Start
May 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hypericum perforatum in obsessive compulsive disorder (OCD), sponsored by National Center for Complementary and Integrative Health. Started May 2002; status: completed.

02

Drugs

hypericum perforatum
03

Conditions

obsessive compulsive disorder (OCD)

Beyond the preview

Go deeper on NCT00035438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00035438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call